Immediate complete revascularization was non-inferior to staged complete revascularization in patients who presented with acute coronary syndrome (ACS) and multivessel disease, according to BIOVASC trial findings.

Acute myocarditis has been identified as a potentially harmful side effect of receiving a COVID-19 vaccine. It is rare enough, however, that cardiologists and cardiology societies still largely agree that the benefits associated with vaccination far outweigh the risks.

Private equity investors have started getting more involved in cardiology in recent years, echoing their rise in radiology, dermatology and other specialties.

Given the long- and short-term harms of opioids, cardiac surgeons stressed that it is feasible to put strict limits around perioperative opioid use without giving up pain control and patient satisfaction.

The 1-year results from the PRECISE Trial were presented at the American Heart Association (AHA) annual congress in Chicago on November 6th. This global, prospective, randomised trial examined a Precision Pathway versus a Traditional Testing pathway for patients with stable chest pain.

Smart technologies are often touted as the answer to some of cardiology’s greatest challenges in patient care and practice. Randy Young | Artificial Intelligence | AI in Healthcare

Seimens go beyond digital with the game changer in PET/CT. Introducing Biograph Vision.

By detecting high-risk plaque, coronary CT angiography (CCTA) can predict major adverse cardiovascular events in patients with stable chest pain, according to a January 10 study in JAMA Cardiology. But the jury is still out on whether CCTA findings should be... By Brian Casey, AuntMinnie.com staff writer